Thorax 1999;54:254-264 ( March )

Review series

Rare diseases  1

Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

Simon Johnson

Division of Respiratory Medicine, University of Nottingham, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK

The first 150 words of the full text of this article appear below.

	Introduction

Lymphangioleiomyomatosis, a rare disease of unknown aetiology, affects women only. It mainly involves the lungs where, as its name suggests, lymphatics (lymph), blood vessels (angio), and airways are surrounded by smooth muscle (leiomyo) proliferation. It is characterised by progressive dyspnoea, haemoptysis, pneumothorax, and chylous pleural effusions and runs a variable course culminating usually in respiratory failure.^1 2 Lymph nodes in the abdomen and pelvis may be involved and up to half the patients have renal angiomyolipomas. The disease usually arises spontaneously although it also occurs in some patients with tuberous sclerosis.³

Much of our knowledge of this unusual disorder is anecdotal, coming from case reports and reviews of patients attending tertiary referral centres, which may not represent the full spectrum of the disease. This will change over the next few years as patient registries are being compiled for research purposes in the United Kingdom, United . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Lynch, J. P. III (2009). Rare Interstitial Lung Diseases: Pulmonary Langerhans Cell Histiocytosis, Lymphangioleiomyomatosis, and Cryptogenic Organizing Pneumonia. ACCP Pulmonary Med Brd Rev 25: 585-618 [Full Text]  
• Rockson, S. G. (2008). Diagnosis and Management of Lymphatic Vascular Disease. J Am Coll Cardiol 52: 799-806 [Abstract] [Full Text]  
• Taveira-DaSilva, A. M., Hathaway, O. M., Sachdev, V., Shizukuda, Y., Birdsall, C. W., Moss, J. (2007). Pulmonary Artery Pressure in Lymphangioleiomyomatosis: An Echocardiographic Study. Chest 132: 1573-1578 [Abstract] [Full Text]  
• Schiavina, M., Di Scioscio, V., Contini, P., Cavazza, A., Fabiani, A., Barberis, M., Bini, A., Altimari, A., Cooke, R. M. T., Grigioni, W. F., D'Errico-Grigioni, A. (2007). Pulmonary Lymphangioleiomyomatosis in a Karyotypically Normal Man without Tuberous Sclerosis Complex. Am. J. Respir. Crit. Care Med. 176: 96-98 [Abstract] [Full Text]  
• Pollock-BarZiv, S., Cohen, M. M, Downey, G. P, Johnson, S. R, Sullivan, E., McCormack, F. X (2007). Air travel in women with lymphangioleiomyomatosis. Thorax 62: 176-180 [Abstract] [Full Text]  
• Pauzner, R., Mayan, H., Waizman, A., Rozenman, J., Farfel, Z. (2007). Successful Thalidomide Treatment of Persistent Chylous Pleural Effusion. ANN INTERN MED 146: 75-76 [Full Text]  
• Clements, D., Mayer, R. J., Johnson, S. R. (2007). Subcellular distribution of the TSC2 gene product tuberin in human airway smooth muscle cells is driven by multiple localization sequences and is cell-cycle dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L258-L266 [Abstract] [Full Text]  
• Tazi, A. (2006). Adult pulmonary Langerhans' cell histiocytosis.. Eur Respir J 27: 1272-1285 [Abstract] [Full Text]  
• Ryu, J. H., Moss, J., Beck, G. J., Lee, J.-C., Brown, K. K., Chapman, J. T., Finlay, G. A., Olson, E. J., Ruoss, S. J., Maurer, J. R., Raffin, T. A., Peavy, H. H., McCarthy, K., Taveira-DaSilva, A., McCormack, F. X., Avila, N. A., DeCastro, R. M., Jacobs, S. S., Stylianou, M., Fanburg, B. L., for the NHLBI LAM Registry Group, (2006). The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 Patients at Enrollment. Am. J. Respir. Crit. Care Med. 173: 105-111 [Abstract] [Full Text]  
• Cohen, M M, Pollock-BarZiv, S, Johnson, S R (2005). Emerging clinical picture of lymphangioleiomyomatosis. Thorax 60: 875-879 [Abstract] [Full Text]  
• Abbott, G. F., Rosado-de-Christenson, M. L., Frazier, A. A., Franks, T. J., Pugatch, R. D., Galvin, J. R. (2005). From the Archives of the AFIP: Lymphangioleiomyomatosis: Radiologic-Pathologic Correlation. RadioGraphics 25: 803-828 [Abstract] [Full Text]  
• Crooks, D. M., Pacheco-Rodriguez, G., DeCastro, R. M., McCoy, J. P. Jr., Wang, J.-a., Kumaki, F., Darling, T., Moss, J. (2004). Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. USA 101: 17462-17467 [Abstract] [Full Text]  
• Johnson, S R, Whale, C I, Hubbard, R B, Lewis, S A, Tattersfield, A E (2004). Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 59: 800-803 [Abstract] [Full Text]  
• Whitsett, J. A., Bachurski, C. J., Barnes, K. C., Bunn, P. A. Jr., Case, L. M., Cook, D. N., Crooks, D., Duncan, M. W., Dwyer-Nield, L., Elston, R. C., Fessler, M. B., Franklin, W. A., Friedman, N., Garcia, J. G. N., Geraci, M. W., Glasgow, C., Glasser, S. W., Hardie, W. D., Henning, L. M., Johnson, G. L., Kawkitinarong, K., Keith, R. L., Korfhagen, T. R., Leikauf, G. D., Liggett, S. B., Malcolm, K. C., Malkinson, A. M., Mariani, T. J., McDowell, S. A., McGraw, D. W., Medvedovic, M., Moss, J., Nogee, L. M., Nonas, S., Pacheco-Rodriguez, G., Palmer, L. J., Peters, D. G., Prows, D. R., Redline, S., Regev, A., Sartor, M. A., Schwartz, D. A., Silverman, E. K., Steagall, W. K., Stearman, R. S., Taveira-DaSilva, A., Tichelaar, J. W., Tomlinson, C. R., Tsukada, K., Weaver, T. E., Wert, S. E., Wesselkamper, S. C., Worthen, G. S., Xu, Y., Zerbe, L., Zhang, Y., Zhang, Y., Choi, A. M. K., Kaminski, N. (2004). Functional Genomics of Lung Disease. Am. J. Respir. Cell Mol. Bio. 31: S1-S81 [Full Text]  
• Evans, S. E., Colby, T. V., Ryu, J. H., Limper, A. H. (2004). Transforming Growth Factor-{beta}1 and Extracellular Matrix-Associated Fibronectin Expression in Pulmonary Lymphangioleiomyomatosis. Chest 125: 1063-1070 [Abstract] [Full Text]  
• Whale, C I, Johnson, S R, Phillips, K G, Newton, S A, Lewis, S A, Tattersfield, A E (2003). Lymphangioleiomyomatosis: a case-control study of perinatal and early life events. Thorax 58: 979-982 [Abstract] [Full Text]  
• Lordan, J L, Gascoigne, A, Corris, P A (2003). The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis. Thorax 58: 814-819 [Full Text]  
• Chan, A. L., Kwack, S., Jones, K. D., Glassberg, M. K., Gherman, C. R. (2003). Lymphangioleiomyomatosis and SZ {alpha}1-Antitrypsin Disease: A Unique Combination?. Chest 124: 763-765 [Abstract] [Full Text]  
• Ryu, J. H., Swensen, S. J. (2003). Cystic and Cavitary Lung Diseases: Focal and Diffuse. Mayo Clin Proc. 78: 744-752 [Abstract]  
• Badawi, R A, Geddes, D M (2003). Exertional haemoptysis: LAM and TSC. Thorax 58: 460-460 [Full Text]  
• Ryu, J. H., Doerr, C. H., Fisher, S. D., Olson, E. J., Sahn, S. A. (2003). Chylothorax in Lymphangioleiomyomatosis. Chest 123: 623-627 [Abstract] [Full Text]  
• Halabi, S., Convery, R., Curtis, J. M. (2002). Progressive Dyspnea in a 49-Year-Old Woman With Long-standing Epilepsy*. Chest 122: 352-355 [Full Text]  
• FRANZ, D. N., BRODY, A., MEYER, C., LEONARD, J., CHUCK, G., DABORA, S., SETHURAMAN, G., COLBY, T. V., KWIATKOWSKI, D. J., MCCORMACK, F. X. (2001). Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis. Am. J. Respir. Crit. Care Med. 164: 661-668 [Abstract] [Full Text]  
• Johnson, S R, Tattersfield, A E (2000). Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 55: 1052-1057 [Abstract] [Full Text]  
• AUBRY, M.-C., MYERS, J. L., RYU, J. H., HENSKE, E. P., LOGGINIDOU, H., JALAL, S. M., TAZELAAR, H. D. (2000). Pulmonary Lymphangioleiomyomatosis in a Man. Am. J. Respir. Crit. Care Med. 162: 749-752 [Abstract] [Full Text]  
• JOHNSON, S. R., TATTERSFIELD, A. E. (1999). Decline in Lung Function in Lymphangioleiomyomatosis . Relation to Menopause and Progesterone Treatment. Am. J. Respir. Crit. Care Med. 160: 628-633 [Abstract] [Full Text]  
• Irani, C., Goncharova, E. A., Hunter, D. S., Walker, C. L., Panettieri, R. A., Krymskaya, V. P. (2002). Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L854-L862 [Abstract] [Full Text]